InvestorsHub Logo

H2R

Followers 42
Posts 2159
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Tuesday, 05/12/2020 1:46:18 PM

Tuesday, May 12, 2020 1:46:18 PM

Post# of 12137

Two Cryoport-supported therapies filed for commercial approval during the first quarter of 2020 and a third filed subsequent to the quarter end, demonstrating the continued focus in the biopharma market on bringing these potentially life-saving therapies to market, even with the current challenges and uncertainties resulting from the COVID-19 pandemic.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News